Explore more publications!

Spain Greenlights Strategy to Combat Influenza, COVID-19

(MENAFN) Spain has greenlit a unified nationwide strategy to combat influenza, COVID-19, and additional respiratory infections, following unanimous approval from the Health Ministry and all 17 autonomous regional health authorities.

Health Minister Monica Garcia announced the breakthrough agreement via X (formerly Twitter) on Wednesday, declaring the rollout of coordinated defensive measures across the nation.

"We approved, together with all the autonomous communities, a Common Protocol against flu, COVID, and other respiratory infections," Garcia posted on the US social media platform.

The comprehensive framework mandates four core interventions: remote work arrangements, mask protocols, vaccination campaigns, and enhanced ventilation systems targeting these illnesses.

Garcia emphasized the life-saving potential of workplace flexibility and protective equipment within medical facilities, stating that teleworking or masks in healthcare centers "save lives."

The minister celebrated the historic consensus, adding: "We said it was necessary and possible. And we have achieved it."

This marks a significant policy shift as Spain consolidates its regional health responses into a single, coordinated national approach against seasonal and emerging respiratory threats.

MENAFN04122025000045017169ID1110435486


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions